Drug profile · INN
emulsion-adjuvanted cell-culture derived influenza ha vaccine (prototype)
EMULSION-ADJUVANTED CELL-CULTURE DERIVED INFLUENZA HA VACCINE (PROTOTYPE) FOR INTRAMUSCULAR INJECTION "KAKETSUKEN"
emulsion-adjuvanted cell-culture derived influenza ha vaccine (prototype) (EMULSION-ADJUVANTED CELL-CULTURE DERIVED INFLUENZA HA VACCINE (PROTOTYPE) FOR INTRAMUSCULAR INJECTION "KAKETSUKEN") is an FDA-listed pharmaceutical active ingredient.
Drug details — emulsion-adjuvanted cell-culture derived influenza ha vaccine (prototype)
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
emulsion-adjuvanted cell-culture derived influenza ha vaccine (prototype) (EMULSION-ADJUVANTED CELL-CULTURE DERIVED INFLUENZA HA VACCINE (PROTOTYPE) FOR INTRAMUSCULAR INJECTION "KAKETSUKEN") is an FDA-listed pharmaceutical active ingredient.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Frequently asked questions
What is emulsion-adjuvanted cell-culture derived influenza ha vaccine (prototype)?
emulsion-adjuvanted cell-culture derived influenza ha vaccine (prototype) (EMULSION-ADJUVANTED CELL-CULTURE DERIVED INFLUENZA HA VACCINE (PROTOTYPE) FOR INTRAMUSCULAR INJECTION "KAKETSUKEN") is an FDA-listed pharmaceutical active ingredient.
What is the brand name for emulsion-adjuvanted cell-culture derived influenza ha vaccine (prototype)?
EMULSION-ADJUVANTED CELL-CULTURE DERIVED INFLUENZA HA VACCINE (PROTOTYPE) FOR INTRAMUSCULAR INJECTION "KAKETSUKEN" is a marketed brand name for emulsion-adjuvanted cell-culture derived influenza ha vaccine (prototype). Check FDA Drugs@FDA for the current US label holder and prescribing information.